Every year, the society names an advance of the year, recognizing effective treatments that help reduce the amount of surgery needed and increase the number of patients who can undergo surgery when needed. It publishes a report, “Clinical Cancer Advances,” that highlights the most important clinical research advances of the year.
For 2020, the society selected “refinement of surgical treatment of cancer” as the advance of the year. This includes a recognition of advances in systemic therapies for pancreatic and kidney cancers and melanoma. In particular, developments in neoadjuvant therapies, which are given before surgery, have helped make surgery for patients with advanced melanoma less invasive.
More articles on clinical leadership & infection control:
Flu sickening children at unusually high rate
Viewpoint: Housekeepers play a valuable role in patient care
9 hospitals hiring chief nursing officers
